Drawing for MEDICAGO

USPTO serial 88064128

MEDICAGO

Reviewed by CopyMark Law Group

Reg. 6533054Status 700Renewal
Filing date
Status date
Registration date
Oct 26, 2021
Examiner
MESSICK, TABITHA LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MEDICAGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle P. Ciotola

Michelle P. Ciotola CANTOR COLBURN LLP20 Church StreetFloor 22Hartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancerACTIVE—
035Wholesale store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies, excluding healthcare plans and healthcare plan management/administration servicesACTIVE—
040Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodiesACTIVE—
042Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidatesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 4, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 21, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Sep 16, 2021APETASSIGNED TO PETITION STAFF—
Sep 9, 2021ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 7, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 23, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 15, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 15, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 15, 2020CNSISUSPENSION INQUIRY WRITTEN—
Mar 15, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 15, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Mar 15, 2020CNSLSUSPENSION LETTER WRITTEN—
Mar 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 19, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 19, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 19, 2019CNSISUSPENSION INQUIRY WRITTEN—
Sep 9, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 6, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 6, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Mar 6, 2019CNSLSUSPENSION LETTER WRITTEN—
Mar 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 2, 2019ALIEASSIGNED TO LIE—
Feb 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2018DOCKASSIGNED TO EXAMINER—
Aug 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance